These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22966094)

  • 1. Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes.
    O'Connor PJ; Vazquez-Benitez G; Schmittdiel JA; Parker ED; Trower NK; Desai JR; Margolis KL; Magid DJ
    Diabetes Care; 2013 Feb; 36(2):322-7. PubMed ID: 22966094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy.
    Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Iwata Y; Sakai N; Takamura T; Kitagawa K; Yoshimura M; Kaneko S; Yokoyama H; Wada T;
    J Diabetes Investig; 2019 Jul; 10(4):1041-1049. PubMed ID: 30516352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.
    Chen G; McAlister FA; Walker RL; Hemmelgarn BR; Campbell NR
    Hypertension; 2011 May; 57(5):891-7. PubMed ID: 21403089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes.
    Vepsäläinen T; Laakso M; Kantola I; Lehto S; Juutilainen A; Rönnemaa T
    J Intern Med; 2012 Dec; 272(6):611-9. PubMed ID: 22891848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of delaying blood pressure control in patients with Type 2 diabetes: results of a decision analysis.
    Laiteerapong N; John PM; Meltzer DO; Huang ES
    J Gen Intern Med; 2012 Jun; 27(6):640-6. PubMed ID: 22215265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of morning home blood pressure measurements in patients with type 2 diabetes mellitus: results of a 10-year, prospective, longitudinal study.
    Kamoi K
    Clin Exp Hypertens; 2015; 37(2):122-7. PubMed ID: 24786228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients.
    Sundström J; Sheikhi R; Ostgren CJ; Svennblad B; Bodegård J; Nilsson PM; Johansson G
    J Hypertens; 2013 Aug; 31(8):1603-10. PubMed ID: 23625112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
    Eur J Prev Cardiol; 2017 Jul; 24(11):1206-1211. PubMed ID: 28470087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease.
    Papademetriou V; Zaheer M; Doumas M; Lovato L; Applegate WB; Tsioufis C; Mottle A; Punthakee Z; Cushman WC;
    Am J Nephrol; 2016; 43(4):271-80. PubMed ID: 27161620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target home morning SBP be below 125 mmHg in type 2 diabetes patients.
    Eguchi K; Hoshide S; Kario K;
    J Hypertens; 2018 Jun; 36(6):1284-1290. PubMed ID: 29369147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.
    Petrie JR; Marso SP; Bain SC; Franek E; Jacob S; Masmiquel L; Leiter LA; Haluzik M; Satman I; Omar M; Shestakova M; Van Gaal L; Mann JF; Baeres FM; Zinman B; Poulter NR;
    J Hypertens; 2016 Jun; 34(6):1140-50. PubMed ID: 26855018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
    Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
    Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk.
    Olsen E; Holzhauer B; Julius S; Kjeldsen SE; Larstorp ACK; Mancia G; Mehlum MH; Mo R; Rostrup M; Søraas CL; Zappe D; Weber MA
    Blood Press; 2021 Apr; 30(2):90-97. PubMed ID: 33403890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale.
    Verdecchia P; Schillaci G; Reboldi G; Borgioni C; Ciucci A; Porcellati C
    Diabetes Nutr Metab; 1999 Aug; 12(4):292-9. PubMed ID: 10782756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial.
    Anderson RJ; Bahn GD; Moritz TE; Kaufman D; Abraira C; Duckworth W;
    Diabetes Care; 2011 Jan; 34(1):34-8. PubMed ID: 21059830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.